Sotrovimab Expanded Access Treatment Protocol
Latest Information Update: 11 Nov 2022
At a glance
- Drugs Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Expanded access; Therapeutic Use
- Sponsors Vir Biotechnology
- 04 Nov 2022 Status changed from recruiting to active, no longer recruiting.
- 15 Feb 2022 New trial record